状细胞疾病的基因疗法在地平线上:临床医生的观点
Henna Butt1,2, John F Tisdale1
1Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Expert review of hematology
|July 30, 2024
概括
基因疗法为状细胞病 (SCD) 提供了有前途的治疗方法,这是一种使人衰弱的遗传疾病,影响了数百万人. 技术的进步使得这些潜在的拯救生命的治疗方法对患有SCD的患者更容易获得.
科学领域:
- 血液学 血液学 血液学
- 遗传医学是一种遗传医学.
- 分子生物学分子生物学
背景情况:
- 状细胞疾病 (SCD) 是一种严重的单一性疾病,在全球引起显著的发病率和过早死亡率.
- 数以百万计的个人受到SCD的影响,突出了迫切需要有效的治疗方法.
- 对SCD的基因疗法研究已取得重大进展,目前有两种FDA批准的产品可供使用.
研究的目的:
- 为当前状细胞疾病的基因治疗方法提供临床视角.
- 探索新的策略,临床进展,以及基因治疗对SCD管理和患者结果的潜在影响.
- 评估基因治疗对SCD患者的风险和益处.
主要方法:
- 使用PubMed,科学网和谷歌学者进行了全面的文献搜索.
- 搜索的重点是1980年至2024年间发表的研究,特别是针对状细胞病和治愈疗法.
- 进行了研究结果的定性审查和综合,以提供专家见解.
主要成果:
- 基因疗法代表了状细胞疾病治愈治疗领域的重大进步.
- 目前的基因疗法技术显示出增加SCD患者治疗治疗的可能性.
- 在大多数临床场景中,SCD基因疗法的潜在益处超过了相关风险.
结论:
- 基因疗法对改变状细胞疾病的管理和预后有很大的前景.
- 基因疗法的持续发展和应用对于解决SCD的全球负担至关重要.
- 临床医师的见解强调了对SCD的可访问和有效的基因治疗的急需.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Multiple Allele Traits
34.1K
The Concept of Multiple Allelism
34.1K
What is Genetic Engineering?
74.0K
Overview
74.0K
Bone Marrow Sampling and Transplants
318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
CRISPR
50.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.2K


